a month ago
CORT
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Industries:
Analyst Ranking
Top 2%
#78 out of 4867 analysts
Average Return
+30.09%
Win Rate
54%62 out of 115
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-02 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-27 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Verona Pharma PLCVRNA | +406.33% | $14.46 | $73.22 | 2024-06-28 - 2025-04-29 | Strong Buy |
Praxis Precision Medicines IncPRAX | +346.23% | $16.16 | $72.11 | 2023-12-04 - 2024-12-03 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
2 months ago
AXSM
3 months ago
CRSP
3 months ago
AXSM
4 months ago
ARGX
4 months ago
AXSM
4 months ago
VRNA
6 months ago
WVE
6 months ago
CPRX
6 months ago
ARGX
6 months ago
CRMD
7 months ago
VRNA
7 months ago
CORT
9 months ago
CPRX
9 months ago
ARGX
10 months ago
VRNA
10 months ago
ARGX
a year ago
CORT
a year ago
ARGX
a year ago
VKTX
a year ago
CORT
a year ago
EDIT
a year ago
CORT
2 years ago
TSHA
2 years ago
SAGE
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +168.43% | Reiterates | 3 days ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +124.12% | Maintains | 22 days ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | +104.83% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 4 | Strong Buy | $50.00 | +509.76% | Maintains | 2 months ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $85.00 | +128.49% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | +81.96% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | +220.86% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $520.00 | +3.28% | Maintains | 3 months ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | +653.14% | Initiates Coverage On | 3 months ago |
Argenx SeARGX | 12 | Strong Buy | $700.00 | +11.20% | Reiterates | 4 months ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | -22.15% | Reiterates | 4 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +424.59% | Initiates Coverage On | 4 months ago |
Wave Life Sciences LtdWVE | 3 | Strong Buy | $36.00 | +390.46% | Maintains | 6 months ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | +48.27% | Maintains | 6 months ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | +416.13% | Maintains | 6 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $8.00 | +5.26% | Maintains | 6 months ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | +86.40% | Maintains | 6 months ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | +0.03% | Downgrades | 7 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Strong Buy | $90.00 | +42.23% | Maintains | 7 months ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | +1,138.39% | Maintains | 9 months ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | +1,718.18% | Maintains | 10 months ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $200.00 | N/A | Reiterates | a year ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 4 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 4 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.